#740 — The Industry Wire

September 19, 2025 Jake Fishman 0 min read
  1. FDA issues warning letters to 100+ drug advertisers.
  2. Ascension cuts operating loss by $1.3B in fiscal 2025.
  3. Nurse practitioner, RN shortage to hit 362k by 2032.
  4. Former Steward hospitals rebrand under single system.
  5. Johns Hopkins and UnitedHealthcare end talks without new deal.
  6. Are Republicans changing their minds about AI safety?
  7. Medicare Advantage plans to share provider directories under CMS final rule.
  8. AI in healthcare: Investors’ green and red flags.
  9. University of Utah Health names first chief innovation officer.
  10. New federal data shows deaths by suicide up 25%.
Get every issue of The Imaging Wire, delivered right to your inbox.

You might also like

Breast Imaging October 23, 2025

Hologic to Go Private in $18.3B Buyout October 23, 2025

Women’s imaging vendor Hologic will go private in an $18.3B buyout led by two private equity firms, Blackstone and TPG. The move is easily the largest acquisition in radiology this year – the question is how it will impact one of the biggest corporate success stories in women’s health.  Hologic has a long history in […]

Breast Imaging October 20, 2025

Cancer Screening Rates Vary Geographically October 20, 2025

Progress has been made in some U.S. regions in boosting adherence rates for cancer screening exams like mammography, but clusters of regional variation remain. That’s according to a new study in JAMA Network Open that offers hope for reducing access disparities in disadvantaged areas. Disparities in healthcare access remain one of the nagging problems in […]

CT Scanners October 16, 2025

Doubling Lung Screening Rates with Patient Outreach October 16, 2025

Low CT lung cancer screening rates have disappointed medical imaging professionals and public health advocates alike since the test received USPSTF recommendation over 10 years ago. But a new study shows how one health system doubled its lung cancer screening rates – to levels approaching those of more established cancer screening exams.  USPSTF recommended low-dose […]